ETBI — Eastgate Biotech Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $3.23m
- $6.30m
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.132 | 0 |
Cost of Revenue | |||||
Gross Profit | — | — | 0 | 0.113 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.606 | 1.66 | 4.82 | 4.3 | 2.82 |
Operating Profit | -0.606 | -1.66 | -4.82 | -4.17 | -2.82 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.026 | -0.054 | -0.099 | -0.022 | -0.009 |
Dividends per Share |